SSM saw operating income of $82.3 million for the first half of 2014, compared with a $1.3 million operating loss in the first six months of 2013. The key drivers of the increase were significant savings from a financial improvement plan the system implemented in the fourth quarter of 2013, in addition to revenue cycle improvements. Operating EBIDA was $221.5 million for the six months ended June 30 of this year, up from $105.3 million in the first half of 2013.
SSM’s overall surplus increased by 55 percent, from $72.2 million in 2013 to $111.7 million for the first half of 2014. Net patient service revenue rose 4.5 percent year-over-year to $71.3 million. While same-hospital acute admissions dropped by 1.3 percent in the first half of 2014 compared with 2013, emergency department visits were up year-over-year by 4.9 percent. Outpatient visits also rose by 1.6 percent.
More articles on health system finances:
8 recent stories on health system financial results
Kaleida expenses down, revenue up in first half of 2014
4 hospitals receive revenue cycle awards
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
